1498.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 11:55):

Stats
本日の出来高	13 000.00
平均出来高	53 974.00
時価総額	288.39M
EPS	HKD0 ( 2024-03-28 )
Last Dividend	HKD0.0191 ( 2017-05-31 )
Next Dividend	HKD0 ( N/A )
P/E	-2.70
ATR14	HKD0 (0.00%)

PuraPharm Corp Ltd 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

PuraPharm Corp Ltd 財務諸表

Annual	2023
収益:	HKD406.86M
総利益:	HKD214.85M (52.81 %)
EPS:	HKD-0.270

FY	2023
収益:	HKD406.86M
総利益:	HKD214.85M (52.81 %)
EPS:	HKD-0.270

FY	2022
収益:	HKD448.07M
総利益:	HKD260.59M (58.16 %)
EPS:	HKD-0.300

FY	2021
収益:	HKD659.59M
総利益:	HKD423.35M (64.18 %)
EPS:	HKD-0.329

Financial Reports:

No articles found.

PuraPharm Corp Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

PuraPharm Corp Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 0.0346 - low (50.00%) | Divividend Growth Potential Score: 1.387 - No dividend growth expected in the near future

Information

First Dividend	HKD0.0840	2016-05-19
Last Dividend	HKD0.0191	2017-05-31
Next Dividend	HKD0	N/A
Payout Date	2017-06-23
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	HKD0.103	--
Avg. Dividend % Per Year	0.00%	--
Score	0.73	--
Div. Sustainability Score	0.0346
Div.Growth Potential Score	1.387
Div. Directional Score	0.711	--

Next Divdend (Est)
(2025-03-31)

HKD0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.73

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
1349.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
0393.HK	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%
6677.HK	Ex Dividend Junior	2023-06-01	Annually	0.00%
1899.HK	Ex Dividend Junior	2023-06-13	Annually	0.00%
0927.HK	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
0057.HK	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
2883.HK	Ex Dividend Knight	2023-06-07	Annually	0.00%
1480.HK	Ex Dividend Knight	2023-06-08	Sporadic	0.00%
0551.HK	Ex Dividend Junior	2023-09-12	Annually	0.00%
8053.HK	No Dividend Player	2023-09-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.261	1.500	-5.21	-7.82	[0 - 0.5]
returnOnAssetsTTM	-0.126	1.200	-4.19	-5.03	[0 - 0.3]
returnOnEquityTTM	-0.574	1.500	-7.49	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.612	0.800	-1.939	-1.552	[1 - 3]
quickRatioTTM	0.225	0.800	-3.38	-2.70	[0.8 - 2.5]
cashRatioTTM	0.0827	1.500	-0.652	-0.978	[0.2 - 2]
debtRatioTTM	0.478	-1.500	2.04	-3.06	[0 - 0.6]
interestCoverageTTM	-1.798	1.000	-1.777	-1.777	[3 - 30]
operatingCashFlowPerShareTTM	0.137	2.00	9.95	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0818	2.00	9.96	10.00	[0 - 20]
debtEquityRatioTTM	2.63	-1.500	10.00	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.528	1.000	4.53	4.53	[0.2 - 0.8]
operatingProfitMarginTTM	-0.121	1.000	-4.42	-4.42	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.134	1.000	-0.367	-0.367	[0.2 - 2]
assetTurnoverTTM	0.482	0.800	-0.119	-0.0956	[0.5 - 2]
Total Score				0.0346

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-2.72	1.000	-0.376	0	[1 - 100]
returnOnEquityTTM	-0.574	2.50	-4.81	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0818	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.137	2.00	9.95	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00588	1.500	-3.29	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.133	1.000	9.18	0	[0.1 - 0.5]
Total Score				1.387

PuraPharm Corp Ltd

PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.